Do we miss changes in Quality of Life? Data from the LuLife project in patients with non-small cell lung cancer in Germany. 7. Juni 2015 von Verschuer, U., Sandner, R., Däßler, K.-U., Tessen, H.W., Münz, M., Spring, L., Jänicke, M., Marschner, N., 2015. Oncol Res Treat 38 (suppl 5)(V45), 13. doi:10.1159/000439070 Abstract Prevention and treatment of chemotherapy-induced neutropenia with the biosimilar filgrastim: a non-interventional observational study of clinical practice patterns. Tesch, H., Ulshöfer, T., Vehling-Kaiser, U., Ottillinger, B., Bulenda, D., Turner, M., 2015. Oncol Res Treat 38, 146–152. doi:10.1159/000381318 Abstract… Weiterlesen Piaza: Non-interventional Study on Efficacy and Safety of Azacitidine (Vidaza®) in Patients with Myelodysplastic Syndromes (MDS, Int-2 or High Risk), AML (WHO 20-30% Blasts), or CMML (10-29% Bone Marrow Blasts Without Myeloproliferative Disorder). Wehmeyer, J., Zaiss, M., Losem, C., Schmitz, S., Neidig, C., Teichmann, B., Harde, J., Trarbach, T., 2015. Oncol Res Treat 38 (suppl.5)(P235), 70. doi:10.1159/000439070… Weiterlesen